1. Peptide-based immunotherapy in multiple myeloma
   Marta Podgórniak et al, 2015, Acta Haematologica Polonica CrossRef
2. Glycan Moieties as Bait to Fish Plasma Membrane Proteins
   Fei Fang et al, 2016, Analytical Chemistry CrossRef
3. The use of signal peptide domains as vaccine candidates
   Riva Kovjazin et al, 2014, Human vaccines & immunotherapeutics CrossRef
4. Characterization of Novel Multiantigenic Vaccine Candidates with Pan-HLA Coverage against Mycobacterium tuberculosis
   Riva Kovjazin et al, 2013, Clinical and Vaccine Immunology CrossRef
5. The use of signal peptide domains as vaccine candidates
   Riva Kovjazin et al, 2014, Human Vaccines & Immunotherapeutics CrossRef
6. Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients
   Lior Carmon et al, 2015, British Journal of Haematology CrossRef
7. Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies: Implications for Cancer Diagnostics and Therapy
   Riva Kovjazin et al, 2014, PLoS ONE CrossRef
8. An antibody‐drug conjugate targeting a GSTA glycosite‐signature epitope of MUC1 expressed by non‐small cell lung cancer
   Deng Pan et al, 2020, Cancer Medicine CrossRef